Copy to clipboard 
Demetra acquired OrthoFundamentals, a U.S.-based manufacturer of implants and sterile-packed, single-use instrument kits for SI Joint Fusion. In conjunction with this acquisition, Demetra launched Demetra Spine, a new global business unit, established to support spinal surgery with forward-thinking value-based solutions.
This acquisition follows Demetra’s majority acquisition of GetSet Surgical, a Swiss-based provider of sterile-packed single-use spine procedure kits, and a strategic asset purchase from Bespoke Technologies, bringing in sterile-packed 3D-printed titanium implants for ACDF procedures.
Demetra Holding formed in 2016 with investment from Tecres and Keensight, which acquired aap Implantate’s biomaterials assets.
Matthew Palmer, Founder and CEO of OrthoFundamentals, stated: “There was a natural synergy and shared vision between OrthoFundamentals and Demetra to differentiate in the market by addressing the primary pain points experienced by providers of spine surgical solutions, particularly in the outpatient ASC settings. We are excited to join the Demetra Spine team and accelerate this vision to lead by being fundamentally different with single-use solutions that are Always Sharp, Always Sterile and Always Ready.
“Demetra brings to market an innovative portfolio of surgery-in-a-box procedural kits ready for immediate use in ASC and Hospital operating rooms, designed to increase productivity, decrease the risk of surgical site infections and deliver value by eliminating sterilization and reprocessing costs – said Ted Bird, Vice President North America, Demetra Spine. Our ambition is to establish a leadership position in the rapidly expanding outpatient spine surgery segment by building a dynamic, market-focused organization, delivering exceptional products, services, and support to our customers”.
“This move represents a bold step in Demetra’s strategy to revolutionize spinal care through innovation, sustainability, and clinical effectiveness. Our ambition is to become the company of choice also in spinal care by developing breakthrough technologies that lower infection risk and set new standards for surgical innovation – commented Michele Perrino, CEO of Demetra. The appointment of Ted Bird to lead the Demetra US Spine Division is a powerful statement of intent — his extensive global commercial leadership experience and deep expertise across orthopedics, spine, neurosurgery, and musculoskeletal care make him the ideal person to drive this next chapter of growth”.
Source: Demetra S.p.A.
Demetra acquired OrthoFundamentals, a U.S.-based manufacturer of implants and sterile-packed, single-use instrument kits for SI Joint Fusion. In conjunction with this acquisition, Demetra launched Demetra Spine, a new global business unit, established to support spinal surgery with forward-thinking value-based solutions.
This acquisition...
Demetra acquired OrthoFundamentals, a U.S.-based manufacturer of implants and sterile-packed, single-use instrument kits for SI Joint Fusion. In conjunction with this acquisition, Demetra launched Demetra Spine, a new global business unit, established to support spinal surgery with forward-thinking value-based solutions.
This acquisition follows Demetra’s majority acquisition of GetSet Surgical, a Swiss-based provider of sterile-packed single-use spine procedure kits, and a strategic asset purchase from Bespoke Technologies, bringing in sterile-packed 3D-printed titanium implants for ACDF procedures.
Demetra Holding formed in 2016 with investment from Tecres and Keensight, which acquired aap Implantate’s biomaterials assets.
Matthew Palmer, Founder and CEO of OrthoFundamentals, stated: “There was a natural synergy and shared vision between OrthoFundamentals and Demetra to differentiate in the market by addressing the primary pain points experienced by providers of spine surgical solutions, particularly in the outpatient ASC settings. We are excited to join the Demetra Spine team and accelerate this vision to lead by being fundamentally different with single-use solutions that are Always Sharp, Always Sterile and Always Ready.
“Demetra brings to market an innovative portfolio of surgery-in-a-box procedural kits ready for immediate use in ASC and Hospital operating rooms, designed to increase productivity, decrease the risk of surgical site infections and deliver value by eliminating sterilization and reprocessing costs – said Ted Bird, Vice President North America, Demetra Spine. Our ambition is to establish a leadership position in the rapidly expanding outpatient spine surgery segment by building a dynamic, market-focused organization, delivering exceptional products, services, and support to our customers”.
“This move represents a bold step in Demetra’s strategy to revolutionize spinal care through innovation, sustainability, and clinical effectiveness. Our ambition is to become the company of choice also in spinal care by developing breakthrough technologies that lower infection risk and set new standards for surgical innovation – commented Michele Perrino, CEO of Demetra. The appointment of Ted Bird to lead the Demetra US Spine Division is a powerful statement of intent — his extensive global commercial leadership experience and deep expertise across orthopedics, spine, neurosurgery, and musculoskeletal care make him the ideal person to drive this next chapter of growth”.
Source: Demetra S.p.A.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
